Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Eiman Ghaffarpasand, M.D. [2]
Abbreviations:
ABG= Arterial blood gas, ANA= Antinuclear antibody, ANP= Atrial natriuretic peptide, ASO= Antistreptolysin O antibody, BNP= Brain natriuretic peptide, CBC= Complete blood count, COPD= Chronic obstructive pulmonary disease, CRP= C-reactive protein, CT= Computed tomography, CXR= Chest X-ray, DVT= Deep vein thrombosis, ESR= Erythrocyte sedimentation rate, HRCT= High Resolution CT, IgE= Immunoglobulin E, LDH= Lactate dehydrogenase, PCWP= Pulmonary capillary wedge pressure, PCR= Polymerase chain reaction, PFT= Pulmonary function test.
Diseases
|
Clinical manifestations
|
Para-clinical findings
|
Gold standard
|
Additional findings
|
Symptoms
|
Physical examination
|
Lab Findings
|
Imaging
|
Histopathology
|
Headache
|
Fever
|
Weight loss
|
Arthralgia
|
Claudication
|
Bruit
|
HTN
|
Focal neurological disorder
|
Biomarker
|
CBC
|
ESR
|
Other
|
CT scan
|
Angiography
|
Ultrasound/ Echocardiography
|
Other
|
Large-Vessel Vasculitis
|
Takayasu arteritis[1]
|
+
|
+/-
|
+
|
-
|
+
|
+
|
+/-
|
+/-
|
MMP-3 and MMP-9
|
Leukocytosis, Anemia
|
↑
|
↑CRP
|
Aneurysmal dilatation of the aorta
|
Blood vessel stenosis
|
Circumferential thickening of the arterial wall (Macaroni sign)
|
PET-scan, Cardiac CT
|
Granulomatous inflammation of arteries
|
Arteriography
|
Coronary aneurysm
|
Giant cell arteritis[2]
|
+
|
-
|
+
|
+/-
|
-
|
-
|
-
|
+/-
|
Pentraxin 3 (PTX3)
|
Normal
|
↑
|
↑CRP
|
Stenosis, Occlusion, Dilatation
|
Aneurysm
|
-
|
Mural inflammation in MRA
|
Granulomatous inflammation of arteries
|
Biopsy
|
Jaw pain and claudication
|
Neurological disease
|
Cerebral aneurysm[3]
|
+
|
-
|
-
|
-
|
-
|
-
|
+/-
|
+
|
-
|
Normal
|
Normal
|
-
|
Well-defined round, slightly hyperattenuating lesion
|
Bulging out of the main lumen
|
-
|
Heterogeneous signal intensity in MRA
|
Layers of smooth muscle cells, Intact endothelium
|
Digital subtraction angiography (DSA)
|
Nausea, Vomiting
|
Neurofibromatosis type 1[4]
|
+/-
|
-
|
+/-
|
-
|
-
|
-
|
+
|
+
|
NF1 mutated gene
|
Normal
|
Normal
|
Neurofibromin gene
|
Bone abnormalities
|
Optical coherence tomography angiography (OCTA)
|
-
|
Optic nerve gliomas in MRI
|
Elongated spindle-shaped cells in neurofibromas
|
NIH diagnostic criteria
|
Cafe au Lait spot
|
Neurofibromatosis type 2[5]
|
+/-
|
-
|
+/-
|
-
|
+/-
|
-
|
-
|
+
|
NF2 mutated gene
|
Normal
|
Normal
|
Schwannomin
|
Meningioma, Schwannoma, Ependymoma
|
Fluorescein angiography showed retinal hamartoma
|
Localized schwannomas in nerve ultrasound
|
Schwannoma in MRI
|
Encapsulated biphasic nerve sheath tumor
|
NIH diagnostic criteria
|
Hearing loss, Vision loss
|
Systemic disease
|
Fibromuscular dysplasia[6]
|
+
|
-
|
+/-
|
+
|
+
|
+
|
+
|
+/-
|
Transforming growth factor β (TGF-β)
|
Normal
|
↑
|
↑ Cr or BUN
|
Alternating stenosis and dilatations in CT angiography
|
Stenosis in the renal arteries
|
Luminal narrowing alternating with dilatation (Beads sign)
|
Focal concentric, long-segment tubular stenosis or outpouching in MRA
|
Fibrodysplastic changes, Collagen deposition
|
Digital subtraction angiography (DSA)
|
Spontaneous coronary artery dissection (SCAD)
|
Ehlers-Danlos syndrome[7]
|
-
|
-
|
-
|
+
|
+/-
|
+/-
|
-
|
+/-
|
TGF-β
|
Normal
|
Normal
|
Cultured skin fibroblasts
|
Multiple vascular segments with aneurysms and dissections
|
Dissection of the posterolateral branch of the left circumflex coronary artery (LCx)
|
Visceral arteries abnormality
|
Vascular abnormalities in MRA
|
Thin and rare collagen bundles in the dermis
|
History and physical examination
|
Bleeding, Bruisability, Heart murmur
|
Polymyalgia rheumatica (PMR)[8]
|
+
|
-
|
+/-
|
+
|
-
|
-
|
-
|
-
|
Plasma fibrinogen
|
Normocytic, normochromic anemia
|
↑
|
CRP
|
Periodontoid localization of calcification
|
Vessel wall thickening, Increased mural contrast enhancement
|
Subacromial or subdeltoid bursitis
|
High F-FDG accumulation around the joints in FDG PET-CT
|
Small angular fibers, Pyknotic nuclear clumps, or target-targetoid fibers
|
-
|
Joint stiffness, Fatigue
|
Amyloidosis[9]
|
+/-
|
-
|
-
|
+/-
|
+/-
|
-
|
+
|
+
|
Immunoglobulin light chain(Amyloid)
|
Anemia
|
Normal
|
↑ Cr or BUN,
↑ ALT or AST
|
Diffusely hypoattenuating and enlarged liver
|
Amyloid deposition in the media and adventitia of small arteries
|
Solid organs increased echogenicity
|
Tc-DPD for cardiac amyloid deposits
|
Extracellular deposition of fibrillar proteins
|
Biopsy
|
Cardiomegaly, Dyspnea
|
References
- ↑ Vaideeswar P, Deshpande JR (2013). "Pathology of Takayasu arteritis: A brief review". Ann Pediatr Cardiol. 6 (1): 52–8. doi:10.4103/0974-2069.107235. PMC 3634248. PMID 23626437.
- ↑ Calvo-Romero JM (2003). "Giant cell arteritis". Postgrad Med J. 79 (935): 511–5. PMC 1742823. PMID 13679546.
- ↑ Stafa A, Leonardi M (2008). "Role of neuroradiology in evaluating cerebral aneurysms". Interv Neuroradiol. 14 Suppl 1: 23–37. doi:10.1177/15910199080140S106. PMC 3328052. PMID 20557771.
- ↑ Cassiman C, Casteels I, Stalmans P, Legius E, Jacob J (2017). "Optical Coherence Tomography Angiography of Retinal Microvascular Changes Overlying Choroidal Nodules in Neurofibromatosis Type 1". Case Rep Ophthalmol. 8 (1): 214–220. doi:10.1159/000469702. PMC 5422752. PMID 28512424.
- ↑ Evans, D G. R (2000). "Neurofibromatosis type 2". Journal of Medical Genetics. 37 (12): 897–904. doi:10.1136/jmg.37.12.897. ISSN 1468-6244.
- ↑ Plouin PF, Perdu J, La Batide-Alanore A, Boutouyrie P, Gimenez-Roqueplo AP, Jeunemaitre X (2007). "Fibromuscular dysplasia". Orphanet J Rare Dis. 2: 28. doi:10.1186/1750-1172-2-28. PMC 1899482. PMID 17555581.
- ↑ Gazit Y, Jacob G, Grahame R (2016). "Ehlers-Danlos Syndrome-Hypermobility Type: A Much Neglected Multisystemic Disorder". Rambam Maimonides Med J. 7 (4). doi:10.5041/RMMJ.10261. PMC 5101008. PMID 27824552.
- ↑ Michet CJ, Matteson EL (2008). "Polymyalgia rheumatica". BMJ. 336 (7647): 765–9. doi:10.1136/bmj.39514.653588.80. PMC 2287267. PMID 18390527.
- ↑ Baker KR, Rice L (2012). "The amyloidoses: clinical features, diagnosis and treatment". Methodist Debakey Cardiovasc J. 8 (3): 3–7. PMC 3487569. PMID 23227278.
Template:WH
Template:WS